Patents by Inventor Mikiyoshi Saito

Mikiyoshi Saito has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7338797
    Abstract: A method, vector, and kit are provided for selectively isolating genes encoding membrane-bound proteins by fusing proteins to a secretable protein having a binding affinity to an antigen (e.g., an antibody), expressing these fusions in host cells, and selectively isolating individual host cells by their ability to bind the antigen via the fusion protein. Host cells expressing fusion proteins that do not contain a membrane binding domain will be relatively unable to bind the antigen, since the fusion proteins in those cells are secreted and unattached to their host cells. The method, vector, and kit disclosed herein are particularly useful for identifying genes for membrane-bound proteins represented in cDNA libraries.
    Type: Grant
    Filed: April 29, 2003
    Date of Patent: March 4, 2008
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Masayuki Tsuchiya, Mikiyoshi Saito, Toshihiko Ohtomo
  • Publication number: 20070281327
    Abstract: Anti-human Mpl antibodies were prepared, and from these three types of antibodies with strong binding activity were selected. An expression system for single-chain antibodies derived from these selected antibodies was constructed using genetic engineering techniques. The anti-human Mpl antibodies and anti-human Mpl single-chain antibodies were assessed for TPO-like agonist activity using BaF3-human Mpl that proliferates TPO-dependently. It was found that while the anti-human Mpl antibodies did not exhibit agonistic activity, the anti-human Mpl single-chain antibodies showed agonistic activity. This shows that when screening for modified antibodies with agonistic activity, it is beneficial to determine agonistic activity after modifying antibodies with antigen-binding activity.
    Type: Application
    Filed: December 10, 2004
    Publication date: December 6, 2007
    Inventors: Kiyotaka Nakano, Junichi Nezu, Takeshi Yoshino, Mikiyoshi Saito, Tetsuro Orita
  • Patent number: 7067297
    Abstract: A DNA encoding a novel protein SMAP-1 having a signal sequence was successfully isolated by screening a cDNA library derived from human fetal hepatocyte using the TMT method developed originally by the inventors. Based on the expression pattern and structural properties, SMAP-1 was suggested to be a molecule playing an important role in living cells.
    Type: Grant
    Filed: February 15, 2001
    Date of Patent: June 27, 2006
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Masayuki Tsuchiya, Mikiyoshi Saito, Hirotaka Ito, Motooki Ashihara, Toshihiko Ohtomo
  • Publication number: 20050019780
    Abstract: A method for isolating a gene encoding a membrane-bound protein characterized by fusing a functional protein with a fused protein itself, which differs from the existing TMT method in which an epitope recognized by an antibody is carried in a fused protein. This method enabled selective isolation of a gene encoding a membrane-bound protein.
    Type: Application
    Filed: August 21, 2003
    Publication date: January 27, 2005
    Inventors: Masayuki Tsuchiya, Mikiyoshi Saito, Toshihiko Ohtomo
  • Publication number: 20030175794
    Abstract: A method for isolating a gene encoding a membrane-bound protein characterized by fusing a functional protein with a fused protein itself, which differs from the existing TMT method in which an epitope recognized by an antibody is carried in a fused protein. This method enabled selective isolation of a gene encoding a membrane-bound protein.
    Type: Application
    Filed: April 29, 2003
    Publication date: September 18, 2003
    Applicant: Chugai Seiyaku Kabushiki Kaisha, a Japanese corporation
    Inventors: Masayuki Tsuchiya, Mikiyoshi Saito, Toshihiko Ohtomo
  • Patent number: 6610485
    Abstract: A method and kit are provided for selectively isolating genes encoding membrane-bound proteins by fusing proteins to a secretable protein having a binding affinity to an antigen (e.g., an antibody), expressing these fusions in host cells, and selectively isolating individual host cells by their ability to bind the antigen via the fusion protein. Host cells expressing fusion proteins that do not contain a membrane binding domain will be relatively unable to bind the antigen, since the fusion proteins in those cells are secreted and unattached to their host cells. The method and kit disclosed herein are particularly useful for identifying genes for membrane-bound proteins represented in cDNA libraries.
    Type: Grant
    Filed: May 2, 2001
    Date of Patent: August 26, 2003
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Masayuki Tsuchiya, Mikiyoshi Saito, Toshihiko Ohtomo
  • Publication number: 20030138802
    Abstract: A DNA encoding a novel protein SMAP-1 having a signal sequence was successfully isolated by screening a cDNA library derived from human fetal hepatocyte using the TMT method developed originally by the inventors. Based on the expression pattern and structural properties, SMAP-1 was suggested to be a molecule playing an important role in living cells.
    Type: Application
    Filed: December 9, 2002
    Publication date: July 24, 2003
    Inventors: Masayuki Tsuchiya, Mikiyoshi Saito, Hirotaka Ito, Motooki Ashihara, Toshihiko Ohtomo